Home » Topics » BioWorld

BioWorld
RSS

THREE BIOTECH COMPANY STOCKS FLY HIGH

Feb. 5, 1991

PROPOSED BUDGET INTRODUCES FDA CHARGES

Feb. 5, 1991

NIH SAYS GENE THERAPY TESTS ON COURSE

Feb. 5, 1991

UNAPPROVED DRUGS IN GULF CHALLENGED

Feb. 4, 1991

INVITRON BOARD URGES LIQUIDATION

Feb. 4, 1991

APPOINTMENTS AND ADVANCEMENTS

Feb. 4, 1991

NEWS BRIEFS:

Feb. 4, 1991

CYGNUS RAISES $25 MILLION IN IPO

Feb. 4, 1991

AMGEN, ENZON QUIT JOINT PEG EFFORT

Feb. 4, 1991

BIOREMEDIATION MAY SEE ACTION IN THE GULF

Feb. 4, 1991

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...